A
ACAD
Acadia Pharmaceuticals Inc
21.74
-0.83-3.68%After Hours: 21.72 -0.02 -0.09%18:48 04/10 EDT
OPEN/PREV CLOSE22.52/22.57
TODAY RANGE21.42-22.60
VOL849.31K
MARKET CAP3.71B
52 WEEK RANGE13.40-28.35
AVG VOL (3M)1.67M
% TURNOVER0.50%
TURNOVER--
P/E (TTM)9.45
% RANGE5.21%
EPS(TTM)2.301
P/E(FORWARD)49.41
P/B3.017
BVPS7.21
DIVIDEND--
P/S3.455
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP3.66B
SHARES OUTSTANDING170.49M
NEXT EARNINGS05/05-05/11
FREE FLOAT168.19M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
Simply Wall St·6m ago
A Look At Acadia Pharmaceuticals (ACAD) Valuation After DAYBUE STIX US Launch
TipRanks·2d ago
RBC Capital Remains a Buy on ACADIA Pharmaceuticals (ACAD)
The Motley Fool·3d ago
Why Neuren shares are rebounding on Wednesday after a brutal 2026 sell-off
Simply Wall St·3d ago
Will DAYBUE STIX Launch Deepen Acadia Pharmaceuticals' (ACAD) Stake in Rett Syndrome Treatment Narrative
Seeking Alpha·04/02 16:49
Biotech Is Holding Steady In 2026
Seeking Alpha·04/02 16:35
Trump may impose tariffs on drugmakers who haven't signed MFN deals - reports
NASDAQ·03/27 15:30
Why Is Acadia (ACAD) Down 12.9% Since Last Earnings Report?
Simply Wall St·03/27 03:08
A Look At ACADIA Pharmaceuticals (ACAD) Valuation After Recent Mixed Share Performance
Benzinga·03/25 19:43
This General Motors Analyst Turns Bullish; Here Are Top 5 Upgrades For Wednesday
Seeking Alpha·03/25 15:51
Acadia Pharma upgraded at BofA following stock pullback
TipRanks·03/25 13:50
Arm upgraded, Mondelez downgraded: Wall Street’s top analyst calls